Chandan Healthcare Limited - IPO
SMEChandan Healthcare Stock Price
Chandan Healthcare IPO Details
Chandan Healthcare IPO Subscription
Chandan Healthcare IPO Application Wise Breakup
Chandan Healthcare IPO Dates
- 10 Feb 2025Opening dateOPD
- 12 Feb 2025Closing dateCOD
- 13 Feb 2025Basis of AllotmentBOA
- 14 Feb 2025Initiation of RefundsIOR
- 14 Feb 2025Credit of SharesCOS
- 17 Feb 2025Listing dateLID
Chandan Healthcare IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retain Minimum | 1 | 800 | ₹127,200 |
| Retain Maximum | 1 | 800 | ₹127,200 |
| HNI Minimum | 2 | 1600 | ₹254,400 |
Chandan Healthcare IPO Reservation
Promoter Holding
Chandan Healthcare IPO Valuations
Chandan Healthcare Limited Financial Information
| Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | ||||||||||||||||||||||||||||||||||||
| Assets | 170.06 | 128.86 | 97.83 | 81.23 | ||||||||||||||||||||||||||||||||||||
| Revenue | 167.99 | 177.96 | 137.03 | 119.92 | ||||||||||||||||||||||||||||||||||||
| Profit After Tax | 17.42 | 16.36 | 3.59 | -1.09 | ||||||||||||||||||||||||||||||||||||
| Net Worth | 41.09 | 27.3 | 23.93 | |||||||||||||||||||||||||||||||||||||
| Reserves and Surplus | 34.31 | 21.16 | 7.37 | 4 | ||||||||||||||||||||||||||||||||||||
| Total Borrowing | 51.92 | 42.01 | 21.36 | 16.58 | ||||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
About Chandan Healthcare IPO
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centres in North India with pathology and radiology testing services.
As of August 31, 2024, the company operates one flagship laboratory, seven central laboratories, and twenty-six satellite centres, with over three hundred collection centres in more than 15 cities across Uttar Pradesh and over 10 in Uttarakhand.
As of August 31, 2024, the company offers 1,118 tests across different specialties. The test menu includes
- 169 routine pathology tests in basic biochemistry and haematology, plus 713 specialized tests like immunohistopathology and molecular pathology, and
- 236 radiology tests, including x-rays, ultrasonography, CT, MRI, and specialized CT scans.
The radiology facilities have eleven CT scanners and four MRI machines.
As of August 31, 2024, the company employed 14 radiologists, 25 pathologists, and over 161 other qualified professionals.
Strength Of Chandan Healthcare IPO
1. Strong Geographical presence in Uttarakhand.
2. Integrated diagnostics provider with one-stop solution offering pathology and radiology testing, and medical consultation services.
3. Track record of profitability and consistent financial performance.
4. Dedicated management team with significant industry experience.
Risk Of Chandan Healthcare IPO
1. Any interruptions at our flagship diagnostic centres may affect our ability to process diagnostic tests, which in turn may adversely affect our business, results of operations and financial condition.
2. Our business and prospects may be adversely affected if we are unable to maintain and grow our brand name and brand image.
3. We are dependent on B2C and few other customers for a major part of our revenues. Further we do not enter long-term arrangements with our customers and any failure to continue our existing arrangements could adversely affect our business and results of operations.
4. Any non-renewal or cancellation of our arrangements with our institutional customers, including hospitals, and government agencies may adversely affect our business, results of operations and financial condition.
5. Our operations are only focused on Uttar Pradesh and Uttarakhand, and any loss of business in such region could have an adverse effect on our business, results of operations and financial condition.
6. Our primary source of revenue is from our pathology and radiology services and our business may be adversely affected if these categories do not perform as well as expected.
7. We are dependent on our Group Company for a significant part of our revenues. Further we have not entered into any long-term arrangements with our group company i.e. Chandan Hospital Limited and any failure to deliver the commitment could adversely affect our business and results of operations.
8. We rely on domestic suppliers for the supply of medical consumables particularly suppliers from Uttar Pradesh and any delay, interruption or reduction in such supply could adversely affect our business, results of operations, financial condition and cash flows.
9. Our contingent liabilities as stated in our Restated Financial Statements could affect our financial condition.
10. We depend on third parties to provide us our reagents and films, and any failure to continue to do so or recall of existing testing equipment and reagents could adversely affect our business, results of operations and financial condition.
Objectives Chandan Healthcare IPO
The company proposes to utilize the Net Proceeds from the Offer towards the following objects:
- Setting up a new Flagship Diagnostic Centre in Jankipuram, Lucknow, Uttar Pradesh.
- Setting up a new Central Reference laboratory at Ayodhya, Uttar Pradesh
- Setting up a new Central Reference laboratory at Ashiyana, Lucknow, Uttar Pradesh.
- General corporate purposes.
Company Contact Details
Chandan Healthcare Limited
Biotech Park, Sector G,
Jankipuram, Kursi Road,
Lucknow-226021
Phone: +91 8429024430
Email: secretarial@chandan.co.in
Website: https://www.chandandiagnostic.com/
Registrar Contact Details
Lead Mangers
Unistone Capital Pvt Ltd
Market Maker
R.K.Stock Holding